A bill to improve outcomes for Medicaid beneficiaries with major depressive disorder or other mental health conditions.
USA117th CongressS-4633| Senate
| Updated: 7/27/2022
Sherrod Brown
Democratic Senator
Ohio
Cosponsors (1)
Finance Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
This bill requires the Centers for Medicare & Medicaid Services to issue guidance for state Medicaid programs on best practices to support individuals with major depressive disorder or other mental health conditions, including options that include pharmacogenetic testing.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in Senate
Read twice and referred to the Committee on Finance.
Health
Drug therapyMedicaidMental healthPrescription drugsState and local government operations
A bill to improve outcomes for Medicaid beneficiaries with major depressive disorder or other mental health conditions.
USA117th CongressS-4633| Senate
| Updated: 7/27/2022
This bill requires the Centers for Medicare & Medicaid Services to issue guidance for state Medicaid programs on best practices to support individuals with major depressive disorder or other mental health conditions, including options that include pharmacogenetic testing.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in Senate
Read twice and referred to the Committee on Finance.
Sherrod Brown
Democratic Senator
Ohio
Cosponsors (1)
Finance Committee
Health
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Drug therapyMedicaidMental healthPrescription drugsState and local government operations